Capital Advisors »

Keros Therapeutics shares owned by Capital Advisors

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 30 0.00
2025-06-30 $0 30 0.00
2025-03-31 $0 16 0.00

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Msci Usa Min Vol (USMV)
Caesars Entertainment (CZR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr S&p Mc 400gr Etf (IJK)
Spdr Series Trust S&p Divid Etf (SDY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)

View all positions for Capital Advisors

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Morgan Stanley
Alkeon Capital Management
Logos Global Management
Geode Capital Management

View all funds holding Keros Therapeutics